Journal Mobile Options
Table of Contents
Vol. 21, No. 3, 2006
Issue release date: February 2006
Section title: Original Research Article
Dement Geriatr Cogn Disord 2006;21:175–181

An Estimate of the Worldwide Prevalence and Direct Costs of Dementia in 2003

Wimo A. · Jonsson L. · Winblad B.
Division of Geriatric Epidemiology, Neurotec, Karolinska Institutet, Stockholm, Sweden
email Corresponding Author

Dr. Anders Wimo

HC Harmånger

Backv 3

SE–820 75 Harmånger (Sweden)

Fax +46 652 71261, E-Mail


  1. Schneider EL, Guralnik JM: The aging of America. Impact on health care costs. JAMA 1990;263:2335–2340.
  2. Rice DP, Fox PJ, Max W, Webber PA, Lindeman DA, Hauck WW, et al: The economic burden of Alzheimer’s disease care. Health Aff (Millwood) 1993;12:164–176.
  3. Jonsson B, Jonsson L, Wimo A: Cost of dementia; in May M, Sartorius N (eds): Dementia. WPA Series Evidence and Experience in Psychiatry. London, Wiley & Sons, 2000, pp 335–363.
  4. Wimo A, Winblad B, Aguero Torres H, von Strauss E: The magnitude of dementia occurrence in the world. Alzheimer Dis Assoc Disord 2003;17:63–67.
  5. Andlin-Sobocki P, Jonsson B, Wittchen HU, Olesen J: Cost of disorders of the brain in Europe. Eur J Neurol 2005;12(suppl 1):1–27.
  6. Jacobzone S, Cambois E, Chaplain E, Robine J: Long term care services to older people, a perspective on future trends: the impact of an improved health of older persons. Report No AWP 4.2. Paris, OECD, 1998.
  7. Fratiglioni L, Rocca WA: Epidemiology of dementia; in Boller F, Cappa SF (eds): Handbook of Neuropsychology, ed 2. Amsterdam, Elsevier, 2001, pp 193–215.
  8. UN: World population prospects: The 1998 revision. World population 1950–2050. New York, United Nations, 1998.
  9. Lobo A, Launer LJ, Fratiglioni L, Andersen K, Di Carlo A, Breteler MM, et al: Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000;54(suppl 5):S4–S9.
  10. Hofman A, Rocca WA, Brayne C, Breteler MM, Clarke M, Cooper B, et al: The prevalence of dementia in Europe: a collaborative study of 1980–1990 findings. Eurodem Prevalence Research Group. Int J Epidemiol 1991;20:736–748.
  11. Rice DP, Hodgson TA, Kopstein AN: The economic costs of illness: a replication and update. Health Financing Rev 1985;7:61–80.
  12. Siegel JE, Torrance GW, Russell LB, Luce BR, Weinstein MC, Gold MR: Guidelines for pharmacoeconomic studies. Recommendations from the panel on cost effectiveness in health and medicine. Panel on cost Effectiveness in Health and Medicine. Pharmacoeconomics 1997;11:159–168.
  13. World Economic Outlook: International Monetary Fund.
  14. World bank classification of economies, 2005.
  15. Håkansson S: Different ways of organizing and financing health care; in Wimo A, Jönsson B, Karlsson G, Winblad B (eds): Health Economics of Dementia. London, Wiley & Sons, 1998, pp 67–97.
  16. Gerdtham UG, Lothgren M: On stationarity and cointegration of international health expenditure and GDP. J Health Econ 2000;19:461–475.
  17. International Monetary Fund: World Economic Outlook Database, 2004.
  18. International Labour Organization: Laborsta Internet, 2004.
  19. Ernst RL, Hay JW: The US economic and social costs of Alzheimer’s disease revisited. Am J Public Health 1994;84:1261–1264.
  20. Manton KG, Corder LS, Clark R: Estimates and projections of dementia-related service expenditures; in Suzman R, Singer B, Manton KG (eds): Forecasting the Health of the Oldest Old. New York, Springer, 1993, pp 207–238.
  21. Ostbye T, Crosse E: Net economic costs of dementia in Canada. CMAJ 1994;151:1457–1464.
  22. Hux MJ, O’Brien BJ, Iskedjian M, Goeree R, Gagnon M, Gauthier S: Relation between severity of Alzheimer’s disease and costs of caring. CMAJ 1998;159:457–465.
  23. McNamee P, Bond J, Buck D: Costs of dementia in England and Wales in the 21st century. Br J Psychiatry 2001;179:261–266.
  24. Smith KA, Shah A: The prevalence and costs of psychiatric disorders and learning disabilities. Br J Psychiatry 1995;166:9–18.
  25. Holmes J, Pugner K, Phillips R, Dempsey G, Cayton H: Managing Alzheimer’s disease: the cost of care per patient. Br J Health Care Management 1998;4:332–337.
  26. Wimo A, Karlsson G, Sandman PO, Corder L, Winblad B: Cost of illness due to dementia in Sweden. Int J Geriatr Psychiatry 1997;12:857–861.
  27. Schulenberg J, Schulenberg I: Cost of treatment and cost of care for Alzheimer’s disease in Germany; in Wimo A, Jonsson B, Karlsson G, Winblad B (eds): The Health Economics of Dementia. London, Wiley & Sons, 1998, pp 217–230.
  28. Kronborg Andersen C, Sogaard J, Hansen E, Kragh-Sorensen A, Hastrup L, Andersen J, et al: The cost of dementia in Denmark: the Odense Study. Dement Geriatr Cogn Disord 1999;10:295–304.
  29. Cavallo MC, Fattore G: The economic and social burden of Alzheimer disease on families in the Lombardy region of Italy. Alzheimer Dis Assoc Disord 1997;11:184–190.
  30. Koopmanschap MA, Polder JJ, Meerding WJ, Bonneux L, van der Maas PJ: Costs of dementia in the Netherlands; in Wimo A, Jonsson B, Karlsson G, Winblad B (eds): The Health Economics of Dementia. London, Wiley & Sons, 1998, pp 207–216.
  31. O’Shea E, O’Reilly S: The economic and social cost of dementia in Ireland. Int J Geriatr Psychiatry 2000;15:208–218.
  32. WHO: World Health report, 2004.
  33. Mathers C, Stein C, Ma Fat D, Rao C, Inoue M, Tomijima N, et al: Global burden of disease 2000. Version 2: methods and results. Global Programme on Evidence for Health Policy Discussion Paper No 50. Geneva, WHO, 2002.
  34. Prince M: Care arrangements for people with dementia in developing countries. Int J Geriatr Psychiatry 2004;19:170–177.
  35. Kabir ZN, Szebehely M, Tishelman C: Support in old age in the changing society of Bangladesh. Ageing Soc 2002;22:615–636.
  36. Logminiene Z, Norkus A, Valius L: Direct and indirect diabetes costs in the world. Medicina (Kaunas) 2004;40:16–26.
    External Resources